Some New Yorkers were surprised when Pfizer’s copay coupons didn’t save them the money they were supposed to. Now, it’s Pfizer’s turn to pay up. The drug giant will shell out $500,000 in fines, fees and costs, plus $200,000 to
read moreFrom pharma exec to attorney general? HHS Secretary Alex Azar is on a list of candidates to replace Attorney General Jeff Sessions if he resigns, The Wall Street Journal reports. But Azar’s not interested in the role, according to the
read moreShire’s $1 billion plasma fractionation plant in Georgia has gone through three owners already since it was envisioned and will soon have a fourth. But after six years, it is now officially open. More: Shire opens B plant to make rare disease
read moreThe basal insulin market is so lousy with pricing pressures—and the products are so costly to make—that Merck has canceled its deal with Samsung Bioepis for a Lantus biosimilar. But even with Merck out of the game, it’s unclear whether
read moreJohnson & Johnson and Bayer’s Xarelto has been losing out to Pfizer and Bristol-Myers Squibb’s Eliquis in the U.S., but it just won a key—and first—FDA win in artery disease that analysts tab at $1.5 billion a year in extra
read moreFrom November 1 specialist clinicians in the UK will be able to prescribe cannabis-derived medicinal products for the first time after a change in the law, the Home Office has confirmed. More: UK doctors allowed to prescribe medical cannabis from
read more© 1994 - 2026 B.M. Pharmaceuticals